Applications of Ethyl 2-Aminopropanoate Hydrochloride in Industrial Manufacturing

Ethyl 2-Aminopropanoate Hydrochloride supports critical synthesis and formulation routes across pharmaceutical, agrochemical, specialty chemical, and research segments. The following sections detail its established industrial applications, relevant compliance frameworks, working concentration ranges, process characteristics, and the main finished articles from downstream users.

1. Pharmaceutical Intermediate for Chiral Alpha-Amino Acid Synthesis

API manufacturers widely select Ethyl 2-Aminopropanoate Hydrochloride as a chiral building block for protected amino acid derivatives. Its hydrochloride salt form allows precise control of enantioselective steps in peptide synthesis and active pharmaceutical ingredient assembly, particularly for molecules requiring S- or R-alanine motifs. Our material positions well in medicinal chemistry operations targeting batch consistency and traceability, and supports GMP validation. Downstream users adjust process loading based on targeted molecule complexity and protection strategy, blending with other amino acid precursors under controlled pH and temperature. This approach yields intermediates necessary for penems, cephalosporins, and peptide APIs.

Industry compliance standards

• Good Manufacturing Practice (GMP) – ICH Q7
• US Pharmacopeia (USP) standards for starting materials
• European Pharmacopoeia (Ph. Eur.) monographs
• FDA 21 CFR Part 210/211 (where applicable for intermediates)

Typical usage ratio

• 10–25% weight in reaction mix, adjusted per molar stoichiometry of target dipeptide or protected alpha-amino acid

Downstream process integration

• Feeds directly into condensation or alkylation steps after dissolution in polar solvent
• Neutralization and deprotection follow before crystallization or chromatographic purification
• Used alongside carboxyl protection reagents and specific chiral auxiliaries in flow or batch reactors

Final product types

• S-tert-butoxycarbonyl-2-aminopropanoic acid
• Protected peptide intermediates for FDA-registered APIs
• Custom chiral alpha-amino acid derivatives

2. Agrochemical Active Ingredient Precursor

Major agrochemical formulators use Ethyl 2-Aminopropanoate Hydrochloride as a functionalized amine building block in selective herbicide and plant growth regulator synthesis. Its stable hydrochloride form supports robust acylation or condensation reactions, allowing manufacturers to introduce amino acid-based structures into new molecule pipelines. Regulatory files reference usage as a starting reagent for actives with enhanced selectivity and environmental degradation. In agrochem R&D, it helps build targeted scaffolds maximizing biological compatibility.

Industry compliance standards

• FAO/WHO Specifications for Agricultural Pesticides
• ISO 9001:2015 Quality Management for chemical manufacturing
• REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) obligations for Europe
• OECD guidelines for chemical testing

Typical usage ratio

• 7–18% weight as a nucleophile or functional group donor, depending on target molecule’s reaction pathway

Downstream process integration

• Charged to synthesis vessel post base catalyst addition
• Reacted under inert atmosphere in presence of acyl chlorides or alkylhalides
• Intermediate isolation by extraction and recrystallization prior to final formulation

Final product types

• Amino acid-derived herbicide active compounds
• Chiral plant growth regulators
• Precursor scaffolds for selective pesticides

3. Research-Scale Peptide Synthesis for CRO/CDMO Labs

Custom synthesis units in contract research organizations and CDMOs procure Ethyl 2-Aminopropanoate Hydrochloride for short peptide stretch assembly and pharmaceutical lead identification. The product’s purity profile aligns with research-grade requirements, especially where fast-track SAR or library enumeration influences selection. Lab chemists dissolve and couple it in parallel synthesis workstations, leveraging its hydrochloride form to reduce base and side-product formation, optimizing sequence yield for proof-of-concept peptides bound for scale-up.

Industry compliance standards

• ISO 9001:2015 (Laboratory Quality Management)
• GLP (Good Laboratory Practice) for non-clinical laboratory studies
• Supplier QC batch traceability documentation
• Internal R&D SOPs for peptide chemistry

Typical usage ratio

• 5–15% molar excess compared to other amino acid building blocks to ensure driving reaction completeness, adjusted per length/complexity

Downstream process integration

• Loaded in automated peptide synthesizers’ feed tanks
• Activated with coupling reagents (e.g., DCC, EDCI) and mixed in solution-phase or solid-phase protocols
• Washing, cleavage, and purification stages follow

Final product types

• Short oligopeptides for screening
• Drug discovery peptide fragments
• Reference standards for pharmacological assays

4. Synthesis of Chiral Catalysts & Ligands for Fine Chemical Manufacturing

Specialty chemical manufacturers source Ethyl 2-Aminopropanoate Hydrochloride to prepare chiral ligands and catalysts essential for enantioselective hydrogenations and asymmetric syntheses. Its amine ester group offers flexible derivatization paths, enabling production of ligands that tune selectivity and yield in metal-catalyzed processes. This application supports high-purity and trace metals-sensitive environments. End users benefit from batch documentation for traceability in regulated sectors such as pharmaceutical and flavor/fragrance ingredient production.

Industry compliance standards

• ISO 9001:2015 certified manufacturing
• Responsible Care Initiative (for specialty chemical stewardship)
• Hazardous Substances Control (local and regional REACH/TSCA reporting)
• Process safety and batch traceability protocols

Typical usage ratio

• 12–22% by mol, often as limiting reagent for chiral center installation, adaptable per target ligand structure

Downstream process integration

• Reacted with metal salts or transition metal complexes in initial ligand construction step
• Sequential derivatization to introduce coordinating groups
• Purification by chromatography or crystallization for further use in homogeneous catalysis

Final product types

• Chiral diamine or bidentate ligand preps
• Specialty catalysts for asymmetric syntheses
• Enantiomerically pure intermediates for next-step functionalization